Davis's Drug Guide
rituximab/hyaluronidase
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
ri-tux-i-mab/hye-al-yoor-on-i-dase
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Rituxan Hycela
- Rituxan SC
Ther. Class.
Pharm. Class.
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Rituximab/hyaluronidase." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110584/all/rituximab_hyaluronidase.
Vallerand AHA, Sanoski CAC, Quiring CC. Rituximab/hyaluronidase. Davis's Drug Guide. F.A. Davis Company; 2024. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110584/all/rituximab_hyaluronidase. Accessed December 18, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Rituximab/hyaluronidase. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110584/all/rituximab_hyaluronidase
Vallerand AHA, Sanoski CAC, Quiring CC. Rituximab/hyaluronidase [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 December 18]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110584/all/rituximab_hyaluronidase.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - rituximab/hyaluronidase
ID - 110584
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110584/all/rituximab_hyaluronidase
PB - F.A. Davis Company
ET - 19
DB - Pediatrics Central
DP - Unbound Medicine
ER -
